Advertisement
Advertisement
U.S. Markets closed
Advertisement
Advertisement
Advertisement
Advertisement

Histogen Inc. (HSTO)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
0.4270-0.0082 (-1.88%)
At close: 04:00PM EST
0.4070 -0.02 (-4.68%)
After hours: 07:59PM EST
Advertisement
Sign in to post a message.
  • R
    Ryan
    New CEO! Histogen has new leadership and can reach its potential and finally drive value for shareholders. Steven Mento is a substantial upgrade.
    Bullish
  • R
    Ryan
    Emricasan -- In September 2021, we, along with our partner Amerimmune announced initiation of a strategic partnering process to further advance the development of emricasan in mild to moderate symptomatic COVID-19
    Bullish
  • g
    gert
    this stock should be over 1
  • j
    josh
    “The Phase 1 trial showed excellent safety in early-stage, mildly symptomatic COVID-19 patients in a small cohort of individuals that received orally-dosed emricasan. Emricasan shortened clinical symptoms and quickened recovery from COVID-19 when compared to placebo group. In addition, the original discovery made by Amerimmune on disease-related biomarkers, including elevated caspase levels, enabled us to focus on understanding how the virus affects the immune system, as opposed to how the body reacts to the coronavirus infection. Most of the current approaches to treating COVID-19 focus on how the body is reacting after the infection. Our approach, with emricasan, is to target the infection with a proactive treatment that prevents an overactive immune system that leads to uncontrolled inflammation and severe symptoms,” said Oral Alpan, MD, CEO of Amerimmune LLC.

    “We are pleased that the positive findings from our emricasan clinical program targeting mild symptomatic COVID-19 patients have been accepted for an oral presentation at this prestigious medical conference and we look forward to supporting our partner Amerimmune as they seek to advance emricasan in the clinic through one or more partnerships,” said Richard W. Pascoe, CEO of Histogen.
  • P
    Pat Walsh
    Is this company still in business?
  • M
    Marie
    anyone else grab panic sale shares under .70?
  • G
    Gregory Smith
    They had a presentation today and the price didn't change. What's going on?
  • R
    Ryan
    The new norm of evolution in Histogen seems to be reward non performance and incompetence. Salary increases, lavish stock options, remodeling offices, for what eroding shareholder value by almost 90 percent and doing offerings with intracoastal a notorious short firm.
  • R
    Ryan
    Richard Pascoe Histogen 540,000 Salary.

    1. 5k revenue last quarter
    2. Suspends flagship hair growth program
    3. Offerings in the pennies
    4. Won’t communicate about Emricasan.
    5. Delisting warning from Nasdaq
    6. Stock falls from 5.00 to .70 cents under leadership.
  • J
    Joe
    Anyone on this conversation board? No posts showing for 5 days
  • P
    Phillip
    Looks like Fidelity took some interest today.
  • g
    gert
    i just bought 1500 shares
  • R
    Ryan
    Pushing the positivities of the drug, the many uses and marketing rollout bodes well for selling Emricasan I doubt they do anything for Covid in my opinion too little amount of participants in trial 1 with no gung-ho willingness to start phase 2.
    Bullish
  • R
    Ryan
    Richard Pascoe is running this like a private company. They didn’t think we had a right to know about finalizing phase 2 design trial and starting the process for partnership. They seem very content to keep price low for their agenda.
  • X
    Xavier
    Should i sell now before the company’s delisted?
  • j
    josh
    HISTOGEN REPORTS THIRD QUARTER 2021 EARNINGS AND PROVIDES BUSINESS UPDATE

    HISTOGEN INC - STRATEGIC PARTNERING PROCESS INITIATED FOR EMRICASAN

    HISTOGEN INC - BELIEVE EXISTING RESOURCES WILL BE SUFFICIENT TO MEET ITS ANTICIPATED CASH NEEDS INTO DECEMBER 2022

    HISTOGEN INC QTRLY LOSS PER SHARE 9 CENTS
  • D
    David
    No more wishfull thinking. SOLD. Good luck.
  • P
    Phillip
    Nice turn upwards today!
    Bullish
  • P
    Phillip
    HC Wainwrights prediction needs to start now!
    Bullish
Advertisement
Advertisement